The rule, which became effective Nov. 30, 2020, is aimed at reducing costs by allowing the importation of certain prescription drugs from Canada.
The new guidance explains how importers can obtain supplies from authorized Section 804 Importation Programs (SIP). The supply chain for each drug must be limited to three entities: one manufacturer, one foreign seller and one importer. Foreign sellers must be licensed to wholesale drugs by Health Canada and registered with the FDA.
The agency retains the authority to not authorize or discontinue a SIP if a foreign seller does not meet all requirements.
The guidance also outlines testing and labeling requirements for all imported drugs.
Read the full guidance here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
